logo
Plus   Neg
Share
Email

Emergent BioSolutions: HHS Increases Task Order By $23 Mln

Emergent BioSolutions Inc. (EBS) said the company continues to be on track with its manufacturing agreements related to COVID-19 vaccines. Also, the company received a contract modification to increase the original task order by $23 million from BARDA. The U.S. Department of Health & Human Services has increased Emergent's task order to purchase additional biologics manufacturing equipment.

Emergent said it expects to align with the U.S. government and AstraZeneca on a mutually agreed ramp down of manufacturing for AstraZeneca's COVID-19 vaccine bulk drug substance.

The company also confirmed that there are no changes to its financial guidance for 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission said people should stop using Peloton Interactive's treadmills "Peloton Tread+" if small children or pets are around. The urgent warning comes less than a month after the exercise equipment maker itself released news of a child's death by a Peloton Tread+ and CPSC's announcement of an investigation into that incident. The Inter-American Development Bank and Citi Innovation Labs have successfully completed a proof-of-concept to make cross-border payments from the U.S. to countries in Latin America and the Caribbean, using blockchain and tokenized money. The platform provided full traceability of the transactions, exchange rates, and fees on blockchain. Australian competition regulator said the country's Federal Court found that Google and its Australian arm misled users about the collection and use of personal location data. The data was collected through Android mobile devices between January 2017 and December 2018. This is said to be the world-first enforcement action brought by the Australian Competition and Consumer Commission or ACCC.
RELATED NEWS
Follow RTT